Skip to main content
CTRE
NYSE Real Estate & Construction

CareTrust Closes First Phase of £1.1B UK Care Home Acquisition, Raises 2026 Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: REIT Stocks · Real Estate
Sentiment info
Positive
Importance info
9
Price
$36.29
Mkt Cap
$8.485B
52W Low
$32.79
52W High
$43.62
52W Position info
11% above low
Off High info
17% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

CTRE is trading near its 52-week low of $32.79 (11% above the low).

Summary

CareTrust REIT closed the first phase of its £1.1 billion acquisition of 45 UK care homes from LNT Care Developments, acquiring 24 homes for ~£576 million (~$764 million) and raising full-year 2026 Normalized FFO guidance to $2.06–$2.09 per share.


Key Events · M&A and Partnerships · CTRE

  • First Closing of £1.1B UK Acquisition

    Completed acquisition of 24 care homes from LNT Care Developments on October 1, 2026 for approximately £576 million (~$764 million), with 21 additional homes under development to be acquired for ~£504 million (~$669 million) through 2027.

  • Revised Full-Year 2026 Guidance Raised

    Normalized FFO guidance increased to $2.06–$2.09 per share (from $2.02–$2.06), Normalized FAD to $2.02–$2.05, and net income to $1.54–$1.57 per share.

  • Record Year-to-Date Investment Activity

    Disclosed approximately $488 million of additional investments closed since Q2 2026 earnings, bringing Q3+ total to ~$1.6 billion and year-to-date to a record $2.7 billion across all three growth engines.

  • SHOP Conversion Pathway

    Homes leased to Crystal Care under 20–21-year triple-net leases with 3% annual escalators during lease-up, converting to RIDEA-compliant SHOP structure upon stabilization with projected mid-to-high 7% stabilized NOI yields.


Analysis · CTRE · Real Estate & Construction

CareTrust REIT completed the first closing of its strategic £1.1 billion (~$1.4 billion) acquisition of 45 UK care homes from LNT Care Developments on October 1, 2026, acquiring 24 completed homes for approximately £576 million (~$764 million). The remaining 21 homes under development will be acquired for approximately £504 million (~$669 million) on a rolling basis through 2027. The transaction is structured with triple-net leases during lease-up, converting to a RIDEA-compliant SHOP structure upon stabilization, with projected stabilized NOI yields in the mid-to-high 7% range. Management simultaneously raised full-year 2026 Normalized FFO guidance to $2.06–$2.09 per share, up from $2.02–$2.06, and disclosed a record $2.7 billion in year-to-date investments. The deal materially expands CareTrust's UK footprint and SHOP platform while providing immediate contractual rental income during the lease-up phase.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CTRE was trading at $36.29 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $8.5B. The 52-week trading range was $32.79 to $43.62. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CTRE - Latest Insights

CTRE
Nov 13, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $38.07
Real-time Price: $37.39 info
Change: -$0.680 (-2%) info
Market Cap: $9.634B info
CTRE
Nov 12, 2026, 12:30 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $37.52
Real-time Price: $37.39 info
Change: -$0.1295 (-0.35%) info
Market Cap: $9.634B info
CTRE
Nov 11, 2026, 4:37 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $39.04
Real-time Price: $37.39 info
Change: -$1.65 (-4%) info
Market Cap: $9.634B info
CTRE
Nov 05, 2026, 4:12 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $37.18
Real-time Price: $37.39 info
Change: +$0.210 (+0.56%) info
Market Cap: $9.634B info
CTRE
Nov 05, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.18
Real-time Price: $37.39 info
Change: +$0.210 (+0.56%) info
Market Cap: $9.634B info